CIK 0001652935 · <br>Emerging growth company
ACTUATE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ACTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473044785
- Phone
- 847-986-4190
- Business address
- 1751 RIVER RUN, SUITE 400, FORT WORTH, TX, 76107
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Director sold 280,000 shares at $5.80 ($1,624,000)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
Page 3 of 10 · 192 filings